97 related articles for article (PubMed ID: 22245188)
1. Effect of gold marker seeds on magnetic resonance spectroscopy of the prostate.
Hossain M; Schirmer T; Richardson T; Chen L; Buyyounouski MK; Ma CM
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):451-8. PubMed ID: 22245188
[TBL] [Abstract][Full Text] [Related]
2. A phase and frequency alignment protocol for 1H MRSI data of the prostate.
Wright AJ; Buydens LM; Heerschap A
NMR Biomed; 2012 May; 25(5):755-65. PubMed ID: 21953616
[TBL] [Abstract][Full Text] [Related]
3. Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe.
Arteaga de Castro CS; Boer VO; Luttje MP; van der Velden TA; Bhogal A; van Vulpen M; Luijten PR; van der Heide UA; Klomp DW
NMR Biomed; 2014 Nov; 27(11):1353-60. PubMed ID: 25212868
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.
Zelefsky MJ; Cohen G; Zakian KL; Dyke J; Koutcher JA; Hricak H; Schwartz L; Zaider M
Cancer J; 2000; 6(4):249-55. PubMed ID: 11038145
[TBL] [Abstract][Full Text] [Related]
6. Assessment of prostatic fiducial marker introduction: patient morbidity, staff satisfaction and improved treatment field placement.
Brown S; Lehman M; Ferrari-Anderson J; Glyde A; Burmeister E; Nicol D
J Med Imaging Radiat Oncol; 2011 Aug; 55(4):417-24. PubMed ID: 21843178
[TBL] [Abstract][Full Text] [Related]
7. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
[TBL] [Abstract][Full Text] [Related]
8. MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification.
Bellomo G; Marcocci F; Bianchini D; Mezzenga E; D'Errico V; Menghi E; Zannoli R; Sarnelli A
PLoS One; 2016; 11(11):e0165730. PubMed ID: 27832096
[TBL] [Abstract][Full Text] [Related]
9. MRI spectroscopy in screening of prostate cancer.
Goeb K; Engehausen DG; Krause FS; Hollenbach HP; Niedobitek G; Buettner M; Frangou P; Engelhard K
Anticancer Res; 2007; 27(1B):687-93. PubMed ID: 17348461
[TBL] [Abstract][Full Text] [Related]
10. [1H magnetic resonance spectroscopy of the prostate].
Mueller-Lisse UG; Scherr M
Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.
Lagemaat MW; Zechmann CM; Fütterer JJ; Weiland E; Lu J; Villeirs GM; Holshouser BA; van Hecke P; Lemort M; Schlemmer HP; Barentsz JO; Roell SO; Heerschap A; Scheenen TW
J Magn Reson Imaging; 2012 Jan; 35(1):166-73. PubMed ID: 21960013
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional proton magnetic resonance spectroscopic imaging with and without an endorectal coil: a prostate phantom study.
Ma C; Chen L; Scheenen TW; Lu J; Wang J
Acta Radiol; 2015 Nov; 56(11):1342-9. PubMed ID: 25348479
[TBL] [Abstract][Full Text] [Related]
13. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
[TBL] [Abstract][Full Text] [Related]
14. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence.
Chen AP; Cunningham CH; Kurhanewicz J; Xu D; Hurd RE; Pauly JM; Carvajal L; Karpodinis K; Vigneron DB
Magn Reson Imaging; 2006 Sep; 24(7):825-32. PubMed ID: 16916699
[TBL] [Abstract][Full Text] [Related]
15. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
16. In vivo prostate magnetic resonance spectroscopic imaging using two-dimensional J-resolved PRESS at 3 T.
Kim DH; Margolis D; Xing L; Daniel B; Spielman D
Magn Reson Med; 2005 May; 53(5):1177-82. PubMed ID: 15844143
[TBL] [Abstract][Full Text] [Related]
17. Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis.
Pels P; Ozturk-Isik E; Swanson MG; Vanhamme L; Kurhanewicz J; Nelson SJ; Van Huffel S
NMR Biomed; 2006 Apr; 19(2):188-97. PubMed ID: 16411280
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of seed reconstruction in prostate postplanning studied with a CT- and MRI-compatible phantom.
De Brabandere M; Kirisits C; Peeters R; Haustermans K; Van den Heuvel F
Radiother Oncol; 2006 May; 79(2):190-7. PubMed ID: 16707176
[TBL] [Abstract][Full Text] [Related]
19. [Spectroscopic imaging (1H-2D-CSI) of the prostate: sequence optimization and correlation with histopathological results].
Stanka M; Eltze E; Semjonow A; Sievert KD; Maier A; Pfleiderer B
Rofo; 2000 Jul; 172(7):623-9. PubMed ID: 10962989
[TBL] [Abstract][Full Text] [Related]
20. Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T.
Cunningham CH; Vigneron DB; Marjanska M; Chen AP; Xu D; Hurd RE; Kurhanewicz J; Garwood M; Pauly JM
Magn Reson Med; 2005 May; 53(5):1033-9. PubMed ID: 15844147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
